Skip to main content
. 2018 May 31;2018(5):CD003220. doi: 10.1002/14651858.CD003220.pub3

41. Pulpotomy (3Mix) versus pulpectomy (3Mix).

Outcome Time point (months) No. of studies Risk ratio (95% CI)
Clinical failure 6 1 3.00 (0.13, 70.83)
12 1 5.00 (0.25, 99.95)
Pain 6 1 3.00 (0.13, 70.83)
12 1 5.00 (0.25, 99.95)
Soft tissue pathology 6 1 Not estimable*
12 1 3.00 (0.13, 70.83)
Pathologic mobility 6 and 12 1 3.00 (0.13, 70.83)
Pathologic radiolucency 6 1 23.00 (1.42, 373.46)
12 1 11.00 (0.64, 190.53)

*due to lack events

Abbreviations ‐ CI: confidence interval; 3Mix: ciprofloxacin + metronidazole + minocycline.